Clinical trial NCT02851225: Coordinate Regulation of Transfusions by Uploading
Official title: Coordinate Regulation of Transfusions by Uploading
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Neoplasm, Uncertain Whether Benign or Malignant
Lead sponsor: University Hospital, Toulouse
Sponsor class: OTHER
First posted: 2016-08-01
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Currently in the Toulouse University Hospital, the organization of transfusion care for patients requiring regular transfusions is based on reading the biological results received by fax before confirming or disproving a planned hospitalization or program a new hospital if needed.

Remote transmission of laboratory results, replacing fax communication might facilitate the coordination of care that results from these laboratory results and provide a better respect of the Plan Custom Care Transfusion (PPST).

The investigators offer organization of transfusion supportive care for patients with conditions requiring biological monitoring using the techniques of information and communication telemedicine.

Primary objective

- Assess the feasibility of setting up an upload procedure biological results in the treatment of transfusion supportive care.

Secondary objectives

* Assess the evolution of the quality of life of patients during the treatment
* Assess changes in patient satisfaction over the support
* Assess the evolution of the satisfaction of the medical team at home and at Toulouse University Hospital
* Describe the programming time (hospitalization, consultations)
* Estimate the loss of biological results
* Assessment of the descriptive use of hospitalization, consultation and biological examinations in both groups. This remedy shall be valued in Euros thanks to GHS rates for hospitalizations, general nomenclature for Professional acts (NGAP) and biology nomenclature (NABM) for biological tests.

Detailed description: Setting up a Custom Care Plan for patients with conditions requiring a transfusion followed , which in its development provides a transfusion Care Custom Program .

The establishment of an electronic transmission enables the regulation of all hospitalizations throughout the patient care pathway and reinforces the link city / hospital through the receipt of laboratory results and issuing information to the partners of the care network patient. The PPST will be transmitted by secure messaging.

The primary endpoint is the proportion of transfusion episodes where PPST is respected. The proportion of patients whose care meets the PPST for 3 successive transfusion episodes will also be estimated.

The secondary endpoints are:

* The Patient satisfaction questionnaires (relative to the consideration of the results, the management procedures) in 3 successive transfusions.
* The Quality of life of the patient assessed by questionnaire (EORTC-QLQC30 and EQ5D) at baseline and after 3 successive transfusion episodes.
* The Satisfaction surveys of the medical team at home and the service effector transfusion at baseline and after 3 successive transfusion episodes.
* The Response time for a hospitalization or consultation program on the study period.
* The Number of lost biological results.
* Evaluation of the descriptive use of hospitalization, consultation, biology.

Eligibility criteria: Inclusion Criteria:

* Patients receiving blood transfusions and / or platelet on our hospital
* Patient agreeing to participate in the project

Exclusion Criteria:

* A patient who can not fill questionaries.
* Absence of social coverage .
* Patient under guardianship or trusteeship safeguard justice

Primary outcomes:
measure: Proportion of transfusion episodes in the Plan Custom Care Transfusion
timeFrame: 12 months
Secondary outcomes:
measure: Quality of life of patients
timeFrame: 12 months
measure: Patients satisfaction
timeFrame: 12 months
measure: Satisfaction of medical team
timeFrame: 12 months
Other outcomes:
Locations:
city: Toulouse
country: France
facility: IUCT-O
Study officials:
affiliation: University Hospital, Toulouse
name: Odile Beyne Rauzy, MD
role: PRINCIPAL_INVESTIGATOR
References: